The Coalition for Affordable Drugs has filed its opposition to Celgene’s motion for sanctions in an IPR, arguing that profit is the motivation behind almost all PTAB petitions. It has also filed three more IPRs, bringing its total to 19
Unlock this content.
The content you are trying to view is exclusive to our subscribers.